Subtopic Deep Dive
Epidemiology of Pemphigoid Diseases
Research Guide
What is Epidemiology of Pemphigoid Diseases?
Epidemiology of pemphigoid diseases studies the incidence, prevalence, geographic variations, temporal trends, and risk factors such as age, comorbidities, and drugs for bullous pemphigoid and related autoimmune subepidermal blistering disorders.
Bullous pemphigoid primarily affects individuals over 70 years, with annual incidence estimated between 2-3 cases per 100,000 in Europe. Recent studies report a growing incidence attributed to population aging, improved diagnostics, and drug triggers. Over 10 population-based studies from 2010-2019 document these trends, including Kridin and Ludwig (2018) analyzing global data.
Why It Matters
Epidemiological data on pemphigoid guides drug safety surveillance, as certain medications trigger cases, informing pharmacovigilance programs (Kridin and Ludwig, 2018; Miyamoto et al., 2019). It supports resource allocation for aging populations in Europe and Asia where incidence rises 2-4 fold over decades. Public health strategies use prevalence maps to predict healthcare burdens, as seen in British guidelines adapting management for increased cases (Harman et al., 2017).
Key Research Challenges
Quantifying Incidence Trends
Distinguishing true rises from diagnostic improvements challenges trend analysis, as registries vary by region (Kridin and Ludwig, 2018). Population aging confounds raw rates, requiring age-standardized metrics. Few longitudinal studies span multiple countries.
Identifying Drug Triggers
Linking drugs to pemphigoid requires case-control designs amid confounding comorbidities (Miyamoto et al., 2019). Drug hypersensitivity classifications complicate attribution (Brockow et al., 2018). Meta-analyses show inconsistent odds ratios across studies.
Mapping Geographic Variations
Incidence differs between Europe (higher) and Asia (lower), but standardized data are scarce. Comorbidities like neurological diseases vary regionally, affecting prevalence estimates. Cross-study comparisons lack uniform diagnostic criteria.
Essential Papers
Mechanisms of Autoantibody-Induced Pathology
Ralf J. Ludwig, Karen Vanhoorelbeke, Frank Leypoldt et al. · 2017 · Frontiers in Immunology · 448 citations
Autoantibodies are frequently observed in healthy individuals. In a minority of these individuals, they lead to manifestation of autoimmune diseases, such as rheumatoid arthritis or Gravesâ disea...
Mechanisms of Disease: Pemphigus and Bullous Pemphigoid
Christoph M. Hammers, John R. Stanley · 2016 · Annual Review of Pathology Mechanisms of Disease · 319 citations
Pemphigus and bullous pemphigoid are autoantibody-mediated blistering skin diseases. In pemphigus, keratinocytes in epidermis and mucous membranes lose cell-cell adhesion, and in pemphigoid, the ba...
British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris 2017
Kristyn Harman, D. Brown, L.S. Exton et al. · 2017 · British Journal of Dermatology · 241 citations
Plain language summary available online
Inherited epidermolysis bullosa
Jo‐David Fine · 2010 · Orphanet Journal of Rare Diseases · 239 citations
Inherited epidermolysis bullosa (EB) encompasses a number of disorders characterized by recurrent blister formation as the result of structural fragility within the skin and selected other tissues....
Pemphigus: Current and Future Therapeutic Strategies
Dario Didona, Roberto Maglie, Rüdiger Eming et al. · 2019 · Frontiers in Immunology · 235 citations
Pemphigus encompasses a heterogeneous group of autoimmune blistering diseases, which affect both mucous membranes and the skin. The disease usually runs a chronic-relapsing course, with a potential...
The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations
Khalaf Kridin, Ralf J. Ludwig · 2018 · Frontiers in Medicine · 232 citations
Bullous pemphigoid (BP) is the most common type of subepidermal autoimmune bullous diseases. BP characteristically affects the elderly and is seen mainly in patients older than 70 years. While the ...
Bullous pemphigoid
Denise Miyamoto, Cláudia Giuli Santi, Valéria Aoki et al. · 2019 · Anais Brasileiros de Dermatologia · 222 citations
Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects elderly individuals. Increase in incidence rates in the past decades has been attributed to population aging, d...
Reading Guide
Foundational Papers
Start with Hammers and Stanley (2016, 319 citations) for disease mechanisms underpinning epidemiology, then Fine (2010, 239 citations) for blistering disease baselines, providing context for incidence patterns.
Recent Advances
Kridin and Ludwig (2018, 232 citations) for incidence trends; Miyamoto et al. (2019, 222 citations) for drug and aging factors; Brockow et al. (2018, 222 citations) for hypersensitivity links.
Core Methods
Age-standardized incidence via registries (Kridin 2018); case-control for risks (Miyamoto 2019); autoantibody mechanisms informing triggers (Ludwig 2017).
How PapersFlow Helps You Research Epidemiology of Pemphigoid Diseases
Discover & Search
Research Agent uses searchPapers with query 'bullous pemphigoid incidence trends' to retrieve 50+ papers including Kridin and Ludwig (2018, 232 citations), then citationGraph maps temporal clusters from 2010-2019. exaSearch uncovers population registries beyond OpenAlex, while findSimilarPapers expands to regional studies like Miyamoto et al. (2019).
Analyze & Verify
Analysis Agent applies readPaperContent on Kridin and Ludwig (2018) to extract incidence rates by country, then runPythonAnalysis with pandas standardizes age-adjusted rates across datasets for verification. verifyResponse (CoVe) cross-checks claims against Hammers and Stanley (2016), with GRADE grading assigning high evidence to trend data due to cohort designs.
Synthesize & Write
Synthesis Agent detects gaps in drug trigger studies via contradiction flagging between Brockow et al. (2018) and Miyamoto et al. (2019), then Writing Agent uses latexEditText for prevalence tables, latexSyncCitations for 20+ refs, and latexCompile to generate a review manuscript. exportMermaid visualizes incidence trend timelines.
Use Cases
"Plot bullous pemphigoid incidence rates by age group from European studies 2010-2020"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib plots rates from Kridin 2018 + Miyamoto 2019) → researcher gets CSV/exported age-incidence graph with statistics.
"Compile LaTeX review on pemphigoid drug triggers with citations"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Harman 2017, Brockow 2018) + latexCompile → researcher gets PDF manuscript with formatted tables/figures.
"Find code for analyzing pemphigoid registry data"
Research Agent → paperExtractUrls (epidemiology papers) → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets R scripts for survival analysis from similar blistering disease repos.
Automated Workflows
Deep Research workflow runs systematic review on 50+ pemphigoid epidemiology papers, chaining searchPapers → citationGraph → GRADE grading for incidence meta-summary report. DeepScan applies 7-step analysis with CoVe checkpoints to verify drug trigger odds ratios from Kridin (2018). Theorizer generates hypotheses on aging-incidence links from Ludwig (2017) mechanisms.
Frequently Asked Questions
What is the definition of epidemiology of pemphigoid diseases?
It examines incidence, prevalence, risk factors like age and drugs, and trends in bullous pemphigoid, the most common subepidermal autoimmune blistering disease affecting elderly patients.
What are key methods in pemphigoid epidemiology?
Population-based registries and age-standardized incidence calculations track trends; case-control studies assess drug triggers, as in Kridin and Ludwig (2018).
What are key papers on pemphigoid epidemiology?
Kridin and Ludwig (2018, 232 citations) overviews growing incidence; Miyamoto et al. (2019, 222 citations) links drugs and aging; Harman et al. (2017, 241 citations) provides management context.
What are open problems in pemphigoid epidemiology?
Standardizing diagnostics across regions for true incidence comparisons; clarifying drug causality amid confounders; predicting trends with population aging.
Research Autoimmune Bullous Skin Diseases with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Epidemiology of Pemphigoid Diseases with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Autoimmune Bullous Skin Diseases Research Guide